High intake of the artificial sweetener sucralose may reduce the efficacy of ICIs in patients with cancer, data suggest.

Prevalence of glycemic control and use of diabetes technology lowest in Hispanic, non-Hispanic Black, Medicaid-insured.

Research links environmental exposures to CKD development and progression. Here’s what clinicians and patients need to know.

Stereotactic ablative body radiation therapy (SABR) is actively being explored for patients with renal cell carcinoma (RCC).

Research teams investigated the association between hemoglobin levels and cognitive impairment in patients with chronic kidney disease (CKD) or end-stage (ESKD).

Improved maximum urinary flow rate and lower International Prostate Symptom Scores seen for adherent versus nonadherent patients.

(HealthDay News) — In 2024, 26.5 percent of adults with diagnosed diabetes used glucagon-like peptide 1 receptor agonist (GLP-1 RA) injectables, according to an August data brief published by the ...

The FDA has approved an expanded indication of the IV formulation of Avtozma to include the treatment of CRS in patients 2 years of age and older.

The Food and Drug Administration (FDA) has approved the first generic version of Venofer ® (iron sucrose) Injection.

Patients who regularly use antiemetic medication, such as for nausea from chemotherapy, appear at increased risk for chronic kidney disease. Patients who use antiemetics have an increased risk of ...

(HealthDay News) — Metformin use is associated with lower risks for dementia and all-cause mortality across body mass index (BMI) groups in patients with overweight or obesity, according to a study ...

DASH, DII are significantly associated with CKD risk, while only DII is associated with CKD severity progression.